ID: ALA4593469

Max Phase: Preclinical

Molecular Formula: C15H17N3O5

Molecular Weight: 319.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1NC(=O)N1C(=O)C[C@@H]1C(=O)NCCC(=O)O

Standard InChI:  InChI=1S/C15H17N3O5/c1-9-4-2-3-5-10(9)17-15(23)18-11(8-12(18)19)14(22)16-7-6-13(20)21/h2-5,11H,6-8H2,1H3,(H,16,22)(H,17,23)(H,20,21)/t11-/m1/s1

Standard InChI Key:  IVVOOUBTAXUXMJ-LLVKDONJSA-N

Associated Targets(Human)

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-4/beta-1 2269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.32Molecular Weight (Monoisotopic): 319.1168AlogP: 0.72#Rotatable Bonds: 5
Polar Surface Area: 115.81Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.81CX Basic pKa: CX LogP: 0.36CX LogD: -2.89
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.69Np Likeness Score: -1.13

References

1. Martelli G, Baiula M, Caligiana A, Galletti P, Gentilucci L, Artali R, Spampinato S, Giacomini D..  (2019)  Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?,  62  (22): [PMID:31670514] [10.1021/acs.jmedchem.9b01000]

Source